• Second quarter revenue was $55.7 million, up 109% from the second quarter 2019 and 26% sequentially
  • Second quarter adjusted EBITDA was $4.1 million compared to ($3.6) million in the first quarter of 2020
  • 2020 Revenue target increased to $215-220 million, up from $200 million

Harvest Health & Recreation Inc. (CSE: HARVOTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today reported its financial and operating results for the second quarter 2020. All financial information is provided in U.S. dollars unless otherwise indicated.

Second Quarter 2020 Financial Results

  • Total revenue in the second quarter was $55.7 million, an increase of 109% from $26.6 million in the second quarter of 2019 and up 26% compared to $44.2 million in the first quarter of 2020.
  • Gross profit excluding biological adjustments in the second quarter was $23.4 million, compared to $6.7 million in the second quarter of 2019 and $18.1 million in the first quarter of 2020.
  • Gross profit margin excluding biological adjustments in the second quarter was 42.1% compared to 25.1% in the second quarter of 2019 and 41.0% in the first quarter of 2020.
  • Net loss was $18.3 million for the second quarter compared to net loss of $25.5 million in the second quarter of 2019 and $20.0 million for the first quarter 2020.
  • Adjusted EBITDA excluding biological adjustments in the second quarter was $4.1 million compared to ($12.4) million in the second quarter of 2019 and ($3.6) million in the first quarter of 2020.

Please see the supplemental information regarding unaudited results and Non-IFRS Financial Measures at the end of this press release.

Second Quarter 2020 Business Highlights

  • Harvest announced the appointment of Deborah Keeley as Chief Financial Officer on June 22, 2020.
  • Harvest completed the initial closing of the divestment of eight retail assets in California to Hightimes Holding Corp. for consideration of $61.5 million, consisting of $1.5 million in cash and $60.0 million in Series A Preferred Stock.
  • As of June 30, 2020, Harvest owned, operated, or managed 35 retail locations in seven states, including 14 open dispensaries in Arizona. Harvest owned and operated dispensaries exclude retail locations serviced through Interurban.
  • As of June 30, 2020, Harvest no longer meets the definition of “foreign private issuer” under United States securities laws as more than 50% of Harvest’s issued and outstanding shares were directly or indirectly owned by shareholders of record domiciled in the United States.  As a result, Harvest will be deemed a U.S. domestic issuer under United States securities laws and will be subject to SEC reporting requirements applicable to U.S. domestic companies no later than January 1, 2021. These U.S. reporting requirements will require Harvest’s financial statements and financial data to be presented under U.S. Generally Acceptable Accounting Principles.

Harvest is increasing its full year 2020 revenue target to $215-220 million, up from the prior target of approximately $200 million. Harvest achieved positive adjusted EBITDA during the second quarter, ahead of the prior guidance of achievement during the second half of 2020. Forecasts assume no meaningful impacts or disruptions to our operations as a result of the COVID-19 pandemic.

Management Commentary
“Our improved financial results during the second quarter demonstrate continued progress toward our primary goal of returning to profitability through revenue growth, cost reduction measures and investments in core markets Arizona, Florida, Maryland, and Pennsylvania,” said Chief Executive Officer Steve White. “We are continuing to build on this positive momentum as we execute on our plan.”

Conference Call & Webcast
Harvest Health and Recreation Inc. will host a conference call and audio webcast with Chief Executive Officer Steve White and Chief Financial Officer Deborah Keeley, Tuesday August 11, 2020 at 5:00 PM Eastern Time.

Registration for this event is required. Please use this link to register:

Following registration, an email confirmation will be sent including dial in details and unique conference call codes. Registration will remain open during the call however we recommend advance registration to access the event.

Second quarter results will be available at:

The live conference call webcast and replay will be available at:

Interim Unaudited Condensed Consolidated Statements of Financial Position
June 30, 2020 and December 31, 2019
(Amounts expressed in thousands of United States dollars) 
June 30,


December 31,


Current assets:
Cash and cash equivalents $ 61,668 $ 22,685
Restricted cash 8,000 8,000
Accounts receivable, net 17,782 12,147
Notes receivable, current portion 47,705 51,349
Biological assets 21,299 8,057
Inventory, net 31,732 28,774
Other current assets 6,866 4,788
Total current assets 195,052 135,800
Notes receivable, net of current portion 39,002 34,430
Property, plant and equipment, net 157,530 149,867
Right-of-use asset, net 55,331 56,955
Intangibles assets, net 233,535 159,209
Corporate investments 19,091
Acquisition deposits 528 3,645
Goodwill 111,459 84,596
Assets held for sale 5,332 2,443
Other assets 17,900 8,619
TOTAL ASSETS $ 834,760 $ 635,564
Current liabilities:
Accounts payable $ 6,478 $ 6,969
Other current liabilities 23,318 21,944
Contingent consideration, current portion 15,904 13,764
Income tax payable 5,644 5,310
Lease liability, current portion 8,501 2,885
Notes payable, current portion 32,711 8,395
Total current liabilities 92,556 59,267
Notes payable, net of current portion 257,549 202,619
Lease liability, net of current portion 49,410 54,621
Deferred tax liability 48,990 28,587
Contingent consideration, net of current portion 1,108 16,249
Other long-term liabilities 480 179
TOTAL LIABILITIES 450,093 361,522
Capital stock 651,505 505,709
Accumulated deficit (273,623) (235,348)
Stockholders’ equity attributed to Harvest Health & Recreation Inc. 377,882 270,361
Non-controlling interest 6,785 3,681
Interim Unaudited Condensed Consolidated Statements of Operations
Three and Six Months Ended June 30, 2020 and 2019
(Amounts expressed in thousands of United States dollars, except share or per share data)
For the three months ended June 30, For the six months ended June 30,
2020 2019 2020 2019
Revenue, net of discounts $ 55,669 $ 26,596 $ 99,905 $ 45,836
Cost of goods sold (32,246) (19,915) (58,332) (31,250)
Gross profit before biological asset adjustments 23,423 6,681 41,573 14,586
Realized fair value amounts included in inventory sold (20,134) (7,740) (29,227) (13,475)
Unrealized fair value gain on growth of biological assets 27,055 13,075 39,873 18,847
Gross profit 30,344 12,016 52,219 19,958
General and administrative 21,498 21,764 45,135 40,150
Sales and marketing 1,246 2,053 2,523 3,642
Share-based compensation 3,276 8,094 17,080 11,397
Depreciation and amortization 3,520 1,600 6,977 3,093
Total expenses 29,540 33,511 71,715 58,282
Operating income (loss) 804 (21,495) (19,496) (38,324)
Other (expense) income
(Loss) gain on sale of assets (1,627) 90 900 90
Other (expense) income 1,205 (200) 10,255 (249)
Foreign currency loss 30 (403) (108) (778)
Interest expense (12,311) (2,439) (19,350) (3,214)
Contract asset impairment (2,420) (2,420)
Loss before taxes and non-controlling interest (14,319) (24,447) (30,219) (42,475)
Income taxes (1,132) (1,637) (4,926) (4,035)
Loss from continuing operations before non-controlling interest (15,451) (26,084) (35,145) (46,510)
Net loss from discontinued operations, net of tax (905) (1,289)
Net loss before non-controlling interest (16,356) (26,084) (36,434) (46,510)
(Loss) gain attributed to non-controlling interest (1,929) 590 (1,841) 968
Net loss attributed to Harvest Health & Recreation Inc. $ (18,285) $ (25,494) $ (38,275) $ (45,542)
Loss per share – basic and diluted $ (0.05) $ (0.09) $ (0.11) $ (0.16)
Attributable to Harvest Health and Recreation Inc. Stockholders $ (0.04) $ (0.09) $ (0.11) $ (0.16)
Attributable to non-controlling interest $ (0.01) $ 0.00 $ (0.01) $ 0.00
Weighted-average shares outstanding – basic and diluted 364,580,737 285,071,254 334,380,082 284,690,893

Non-IFRS Financial and Performance Measures

The Company provides additional financial metrics that are not prepared in accordance with IFRS. Management uses non-IFRS financial measures, in addition to IFRS financial measures, to understand and compare operating results across accounting periods, for financial and operational decision making, for planning and forecasting purposes and to evaluate the Company’s financial performance. This non-IFRS financial measure is Adjusted EBITDA.

Management believes that these non-IFRS financial measures reflect the Company’s ongoing business in a manner that allows for meaningful comparisons and analysis of trends in the business, as they facilitate comparing financial results across accounting periods and to those of peer companies. Management also believes that these non-IFRS financial measures enable investors to evaluate the Company’s operating results and future prospects in the same manner as management. These non-IFRS financial measures may also exclude expenses and gains that may be unusual in nature, infrequent or not reflective of the Company’s ongoing operating results.

As there are no standardized methods of calculating these non-IFRS measures, the Company’s methods may differ from those used by others, and accordingly, the use of these measures may not be directly comparable to similarly titled measures used by others. Accordingly, these non-IFRS measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS.

Reconciliations of Non-IFRS Financial and Performance Measures
The table below reconciles Net Loss to Adjusted EBITDA for the periods indicated.
Three months ended June 30, Six months ended June 30,
2020 2019 2020 2019
Net loss (IFRS) before non-controlling interest $ (16,356) $ (26,084) $ (36,434) $ (46,510)
Add (deduct) impact of:
Net interest and other financing costs (1) 12,532 2,961 19,737 3,736
Income tax 1,132 1,637 4,926 4,035
Amortization and depreciation (2) 4,599 2,130 8,840 4,206
(Gain) loss on assets 1,627 (90) (900) (90)
Other (expense) income (1,205) 200 (10,255) 249
Foreign currency loss (30) 403 108 778
Share-based compensation expense 3,276 8,094 17,080 11,397
Contract asset impairment 2,420 2,420
Discontinued operations, net of tax 905 1,289
Realized fair value amounts included in inventory sold 20,134 7,740 29,227 13,475
Unrealized fair value gain on growth of biological assets (27,055) (13,075) (39,873) (18,847)
Other expansion expenses (pre-open) 1,203 1,365 2,926 2,495
Transaction & other special charges 955 2,336 1,402 7,956
Adjusted EBITDA (non-IFRS) $ 4,137 $ (12,383) $ 493 $ (17,120)
(1) Includes $221, $522, $387 and $522 of interest reported in cost of sales.
(2) Includes $1,079, $530, $1,863 and $1,113 of depreciation reported in cost of sales.

About Harvest Health & Recreation Inc.

Headquartered in Tempe, Arizona, Harvest Health & Recreation Inc. is a vertically integrated cannabis company and multi-state operator. Since 2011, Harvest has been committed to expanding its retail and wholesale presence throughout the U.S., acquiring, manufacturing, and selling cannabis products for patients and consumers in addition to providing services to retail dispensaries. Through organic license wins, service agreements, and targeted acquisitions, Harvest has assembled an operational footprint spanning multiple states in the U.S. Harvest’s mission is to improve lives through the goodness of cannabis. We hope you’ll join us on our journey: https://harvesthoc.com 

Facebook: @HarvestHOC
Instagram: @HarvestHOC
Twitter: @HarvestHOC

Forward-looking Statements

This press release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of Harvest with respect to future business activities. Forward-looking information is often identified by the words “may,” “would,” “could,” “should,” “will,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “expect” or similar expressions and include information regarding: (i) expectations regarding the size of the U.S. cannabis market, (ii) the ability of the Company to successfully achieve its business objectives, (iii) plans for expansion of Harvest, and (iv) expectations for other economic, business, and/or competitive factors.

Investors are cautioned that forward-looking information is not based on historical facts but instead reflects Harvest management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Harvest believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the combined Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the effects of the weather, natural disasters, and health pandemics, including the novel coronavirus (COVID-19), on customer demand, the Company’s supply chain as well as its consolidated results of operation, financial position and cash flows, the ability of Harvest to open additional retail locations and meet its revenue growth and profitability objectives, the ability of Harvest to integrate recent acquisitions, the ability of Harvest to obtain and/or maintain licenses or other contractual rights to operate in the jurisdictions in which it operates or in which it expects or plans to operate; changes in general economic, business and political conditions, including changes in the financial markets; and in particular in the ability of Harvest to raise debt and equity capital in the amounts needed and at the costs that it expects; adverse changes in the public perception of cannabis; decreases in the prevailing prices for cannabis and cannabis products in the markets that Harvest operates in; adverse changes in applicable laws; or adverse changes in the application or enforcement of current laws, including those related to taxation; and increasing costs of compliance with extensive government regulation. This forward-looking information may be affected by risks and uncertainties in the business of Harvest and market conditions.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although Harvest has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Harvest does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Additional Information

The financial information reported in this news release is based on unaudited management prepared financial statements for the quarter ended June 30, 2020. Accordingly, such financial information may be subject to change. Financial statements for the period will be released and filed under the Company’s profiles on SEDAR at www.SEDAR.com by August 28, 2020. All financial information contained in this news release is qualified in its entirety with reference to such unaudited financial statements. While the Company does not expect there to be any material changes, to the extent that the financial information contained in this news release is inconsistent with the information contained in the Company’s unaudited financial statements, the financial information contained in this news release shall be deemed to be modified or superseded by the Company’s unaudited financial statements. The making of a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation for purposes of applicable securities laws.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/harvest-health–recreation-inc-reports-second-quarter-2020-financial-results-301110269.html

SOURCE Harvest Health & Recreation Inc.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/August2020/11/c0331.html

Investor, Christine Hersey, Director of Investor Relations, +1 (424) 202-0210, chersey@harvestinc.com, www.harvestinc.comCopyright CNW Group 2020

News Provided by Canada Newswire via QuoteMedia

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less